Summary of Classification and Labelling
Notified classification and labelling
General Information
813-966-0 |
2-[1-(2-{4-[2-(4,4-dimethyl-4,5-dihydro-1,3-oxazol-2-yl)propan-2-yl]phenyl}ethyl)piperidin-4-yl]-1H-1,3-benzodiazole |
202189-81-9 |
Notified classification and labelling according to CLP criteria
Not Classified |
|
|
|
|
|
|
|
|
2 |
|
|
Muta. 2 |
H341
(inhalation)
|
|
|
GHS08 Wng
|
|
|
|
|
1 |
|
View details
|
Number of Aggregated Notifications: 2